Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.00
Bid: 43.80
Ask: 44.50
Change: -0.85 (-1.89%)
Spread: 0.70 (1.598%)
Open: 44.00
High: 44.00
Low: 44.00
Prev. Close: 45.00
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful defence of patent infringement in Asia

27 Nov 2018 07:00

RNS Number : 5471I
Benchmark Holdings PLC
27 November 2018
 

 

27 November 2018

 

 

Benchmark Holdings plc

("Benchmark", the "Company" or the "Group")

 

Successful defence of patent infringement in Asia

 

Benchmark Holdings, the aquaculture genetics, health and nutrition business, announces that it has successfully prosecuted infringement of its patents by Marine-Tech International ("MTI") in Thailand (Thai Patent No. 38834 and Thai Patent No. 47896). The IP&IT court in Bangkok, Thailand has ruled that MTI infringed both patents, has ordered MTI to cease using Benchmark's patented technology and has awarded damages in Benchmark's favour, which may yet be subject to appeal.

 

These patents relate to the Company's market leading Artemia hatching and enrichment technologies, an important element of its advanced nutrition solutions. Following a period of dialogue with MTI, during which the Company requested MTI to cease and desist from using its patented technology, the Group filed a complaint at the IP&IT court in Bangkok in 2017. The summary judgement in favour of Benchmark was announced on 22nd November 2018.

 

The Company actively protects intellectual property rights, and this success demonstrates the robustness of Benchmark's patents and its ability to defend them globally in key markets.

 

Benchmark has a strong patent portfolio across products and processes in all of its three main divisions, which is the result of its advanced innovation, research and development and associated investment over the years. The Company's portfolio with 37 families and 221 patents is well balanced, with a mixture of robust granted applications to protect current products and new patent applications to support the business in the future.

 

Commenting on the Court ruling, Malcolm Pye, CEO, said:

 

"We are pleased the IP&IT court in Bangkok has ruled in our favour, vindicating the intellectual property which underpins the value of our innovative solutions and future product pipeline. Robust intellectual property protection will continue to be a core strategic area of focus for the Group."

 

Athene Blakeman, Group Legal Counsel, said:

 

"Benchmark robustly protects its intellectual property assets across the world and proactively monitors the market and our competitors for infringement. This intellectual property has been developed through many years of investment in cutting edge R&D and, while Benchmark strongly supports open and fair competition, we will take all necessary action, including initiating legal procedures as in this case, where we identify unfair infringement of our intellectual property."

 

 

For further information, please contact:

 

Benchmark Holdings plc

Tel: 020 7260 1000

Malcolm Pye, CEO

Ivonne Cantu, Investor Relations Director

Rachel Aninakwah, Communications

Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

MHP

Katie Hunt / Reg Hoare /Alistair de Kare-Silver

Tel: 020 3128 8742 07551 170 451

benchmark@mhpc.com

 

Notes to Editors:

 

Benchmark challenges the status quo in aquaculture. Since 2000, Benchmark has consistently worked to build a technology-rich platform in the areas of genetics, advanced nutrition, animal health and knowledge services to serve its customers, helping them improve yield and efficiency in a sustainable way.

 

The Company has leading positions in its core markets and established R&D, manufacturing and distribution capabilities to serve all the major aquaculture markets. Benchmark operates in 27 countries and as at 31 March 2018 employed 1,028 people.

 

For further information on Benchmark please visit www.benchmarkplc.com@WeAreBenchmark

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAGMMZMRVDGRZM
Date   Source Headline
21st Jun 20214:36 pmRNSPrice Monitoring Extension
2nd Jun 20214:41 pmRNSSecond Price Monitoring Extn
2nd Jun 20214:35 pmRNSPrice Monitoring Extension
28th May 20217:00 amRNSTotal Voting Rights
25th May 20217:00 amRNSDirector Dealings
18th May 20217:00 amRNSSecond Quarter and Interim results
30th Apr 20217:00 amRNSTotal Voting Rights
19th Apr 20217:00 amRNSNotice of Q2 and Interim Results
16th Apr 202111:00 amRNSBMK08+CleanTreat Update
31st Mar 20213:41 pmRNSDirector Dealings
31st Mar 20217:00 amRNSTotal Voting Rights
30th Mar 20217:00 amRNSListing of existing senior secured NOK bond
26th Mar 20218:24 amRNSBMK08+CleanTreat Update
19th Mar 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
26th Feb 202110:52 amRNSTotal Voting Rights
22nd Feb 20217:00 amRNSQ1 Results
9th Feb 202112:43 pmRNSResult of AGM
9th Feb 20217:00 amRNSNotice of Q1 Results
29th Jan 20217:00 amRNSTotal Voting Rights
13th Jan 20217:00 amRNSIssue of Equity
8th Jan 20211:13 pmRNSReplacement: DIRECTOR SHARE OPTIONS
8th Jan 20219:57 amRNSDIRECTOR SHARE OPTIONS
6th Jan 20213:45 pmRNSDirector Dealings
31st Dec 20207:00 amRNSTotal Voting Rights
11th Dec 20205:32 pmRNSPosting of Annual Report and Notice of AGM
2nd Dec 20202:09 pmRNSDirector Dealings
1st Dec 20204:02 pmRNSAnnual Financial Report
1st Dec 202011:30 amRNSDirector Dealings
1st Dec 202010:30 amRNSDirector Dealings
1st Dec 202010:21 amRNSPCA Dealing
30th Nov 20207:00 amRNSTotal Voting Rights
27th Nov 20207:00 amRNSQ4 Results
27th Nov 20207:00 amRNSFull Year Results
18th Nov 20207:00 amRNSDirectorate Change
4th Nov 20207:00 amRNSInvestor Presentation for Retail Investors
30th Oct 20207:00 amRNSTotal Voting Rights
27th Oct 20207:00 amRNSNotice of Results
13th Oct 20202:29 pmRNSHolding(s) in Company
12th Oct 20202:50 pmRNSHolding(s) in Company
30th Sep 20207:00 amRNSTotal Voting Rights
29th Sep 20207:00 amRNSHolding(s) in Company
21st Sep 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Sep 20205:58 pmRNSHolding(s) in Company
10th Sep 20209:15 amRNSPositive Opinion from the EMA on BMK08
4th Sep 20207:00 amRNSDirector/PDMR Shareholding
28th Aug 20207:00 amRNSTotal Voting Rights
28th Aug 20207:00 amRNSQ3 Results
21st Aug 20207:00 amRNSNotice of Q3 Results
31st Jul 202011:17 amRNSCompletion of sale of vaccine facility
31st Jul 20207:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.